overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
Published 2 years ago • 492 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
0:50
investigating mechanisms of resistance to cdk4/6 inhibitors
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
1:14
endocrine therapy resistance in er metastatic breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
3:14
tff1 and tff3 predict response to cdk4/6 inhibitors in breast cancer patients
-
4:54
monarch 3 study: cdk4/6 inhibitors in the treatment of metastatic breast cancer
-
1:22
dr. rugo on resistance to cdk4/6 inhibitors in hr breast cancer
-
2:40
resistance to cdk4/6 inhibitors
-
5:07
what is the role of cdk4/6 inhibitors in early breast cancer?
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
26:34
cdk 4/6 inhibitors in breast cancer advanced and adjuvant settings
-
1:12
remaining questions on the use of frontline cdk4/6 inhibitors endocrine therapy
-
8:42
hr mbc: treatment after progression on cdk4/6 inhibition
-
3:01
assessing elacestrant in ctdna-positive patients with er breast cancer
-
2:19
cdk 4/6 inhibitors for patients with recurrent er /her2- breast cancer: 2023 best of breast
-
2:52
mechanisms of resistance to cdk4/6 inhibitors in triple negative breast cancer
-
1:13
dr. jhaveri on acquired resistance to cdk 4/6 inhibitors in breast cancer
-
3:35
overcoming resistance in er breast cancer